Select Page
When every second counts…

Instant Access to Overdose Medication

The CounterAct Cap is a novel nasal delivery system. The cap snaps directly on top of the prescription bottle and can contain rescue medication, such as Naloxone to be administered nasally in the event of an opioid overdose.

The CounterAct Cap is US patented

CounterAct is seeking drug development partners to advance this novel technology to save lives and mitigate the Opioid Overdose Epidemic.

People die each day from opioid-related drug overdose³

People misuse prescription opioids annually²

People died from opioid overdoses in 2020⁴

People had an opioid use disorder in 2019⁶

Economic Burden of prescription opioid misuse in the United States¹

Deaths attributed to overdose on commonly prescribed opioids in 2017²

Deaths attributed to overdose on synthetic opioids other than methadone in 2019⁵

Adolescents started to misuse prescription pain medications in 2017

A person is more likely to die from an accidental opioid overdose than from a motor vehicle crash.⁷

Re-Imagining Opioid Overdose Treatment

 

CounterAct has developed a US patented, Nasal Delivery Device that snaps on top of any bottle of prescription medicine. Underneath the outer cap is a nasal delivery system consisting of a stowed nasal nozzle that can be extended and inserted into a nostril in the event of an opioid overdose. With minimal pressure, the spring-loaded trigger can be pushed and the rescue medication can be nasally administered.

CounterAct Nasal Device User Preference Study

With nearly 255 people dying in the United States every day from opioid overdoses, the Opioid Overdose Epidemic has showed no signs of slowing (1). In 2017, The United States Health and Human Services (HHS) developed a 5 Point Strategy to address the opioid epidemic....

read more

Counteracting the Effects of an Opioid Overdose

This article is taken from Pharmaceutical Manufacturing and Packing Sourcer February 2020, Supplement, pages 6-7. © Samedan Ltd. Respiratory depression can occur from accidental and/or intentional overdose of opioid type substances. The neurochemical process, by which...

read more

Contact Us

Todd Pizitz, Ph.D.

Phone: 619-507-7907

Don R. Mealing

Phone: 949-690-9900

Sources: 1 National Institute on Drug Abuse, 2 “economic burden” of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.2, 2 hhs.gov, 3 A Time of Crisis for the Opioid Epidemic in the USA, volume 398, Issue 102977, p277., 4 Centers for Disease Control gov, 5 drugabuse.gov, 6 samhsa.gov, 7 4 National Safety Council, January 2019